区分第三代抗精神病药物:聚焦卢马特佩龙的相似之处和差异
Gloria M Munayco Maldonado1, Thomas L Schwartz2
1Medical Student, Norton College of Medicine at SUNY Upstate Medical University.
International clinical psychopharmacology
|October 2, 2023
概括
本综述比较了四种非典型的抗精神病药物:卢马特佩龙,阿里皮普拉,布雷克斯皮普拉和卡里普拉. 虽然疗效相似,但这些多巴胺-2受体部分激动剂的副作用,如体重增加和外皮拉米德症状的差异显著.
科学领域:
- 药理学和精神病学 药理学和精神病学
- 神经科学是一个神经科学.
背景情况:
- 非典型的抗精神病药物已经发展,新的药物表现出明显的药理动力学特征.
- 卢马特佩龙,阿里皮普拉,布雷克斯皮普拉和卡里普拉是多巴胺-2受体的部分激动剂,具有不同的受体亲和力.
研究的目的:
- 为了比较四种特定的非典型抗精神病药物的临床和药学动力学差异.
- 评估这些药物作为第三代抗精神病药物的潜在分类.
主要方法:
- 进行了PubMed对临床前和临床研究的搜索.
- 从动物模型和人类实验对药理机制,临床疗效和不良影响的数据汇总.
主要成果:
- 在四种药物中,对于共享的适应症的临床疗效似乎是可比的.
- 副作用的概况有显著的差异,特别是体重增加和额外金字塔症状 (EPS).
- 卢马特佩龙的体重增加率最低;布雷克西普拉的食欲增加率最高. 阿里皮普拉佐尔的非白性EPS是最低的;卡里普拉津的最高.
结论:
- 审查的非典型抗精神病药物表现出相似的疗效,但由于不同的受体亲和关系,具有不同的不良反应概况.
- 根据特定的药物及其受体结合特征,患者可能会观察到不同的临床效应.
更多相关视频
相关概念视频
Antipsychotic Drugs: Typical and Atypical Agents
234
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
234
Antidepressant Drugs: MAOIs and Other Agents
266
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
266
Drug Therapy
60
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
60
Psychosis: Goals of Pharmacotherapy
158
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
158
Mania and Antimanic Drugs: Overview
215
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
215
Psychosis and Antipsychotic Drugs: Overview
307
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
307


